A device developed by a Georgia Tech biomedical engineering professor that uses artificial intelligence (AI) to improve the treatment process for those with structural heart disease received FDA clearance in June.
Precision TAVI is an (AI)-driven individualized computer predictive modeling tool that can be used to improve patient outcomes, enhanced lifetime planning, and reduced costs associated with treating those needing transcatheter aortic valve replacement.
Lakshmi (Prasad) Dasi, a professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Tech, is the founder and chief technology officer for Dasi Simulations, the company behind the Precision TAVI.
“DASI Simulations empowers every heart team with critical insights guaranteeing the identification of the best possible care for individual patients, customized to their unique circumstances and anatomy, Dasi said. “One surgery at a time, our technology helps avoid complications, repeated interventions, helps lifelong planning for optimal structural heart care, and has the potential to save billions in unnecessary costs from preventable complications.”
Latest BME News
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder
Researchers develop spatial transcriptomics toolkit that provides new insights into the molecular processes of life
Air Detectives take top prize to give department three straight victories in Expo competition
Coulter BME community gathers at the Fabulous Fox to celebrate anniversary of unique public-private partnership
Coskun pioneering new research area and building a company around iseqPLA technology
BME undergraduate student and competitive skater Sierra Venetta has found success on and off the ice
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients